Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Mater Sci Mater Med ; 24(7): 1683-92, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23588672

RESUMEN

Novel copolymers of vinyl acetate and dialkylfumarates, poly(VA-co-DRF) with R = isopropyl (DIPF) or octan-2-yl (DOF), were synthesized by radical copolymerization under microwave conditions. The products were characterized by (1)H NMR and FTIR spectroscopies, size exclusion chromatography and differential scanning calorimetry. Based on these copolymers three membranes supported on polyvinyl alcohol were prepared and their morphology, swelling and mechanical properties were studied. The swelling kinetic was analyzed and interpreted in light of the Fick transport model, showing that the water transport occurs through a non-Fickian diffusion mechanism. The results show that the membrane prepared of poly(VA-co-DOF) exhibited excellent properties as potential platform for transdermal delivery system: they exhibited good tensile strength, moderated swelling and form thin and transparent films.


Asunto(s)
Fumaratos/química , Fumaratos/síntesis química , Membranas Artificiales , Parche Transdérmico , Administración Cutánea , Portadores de Fármacos/síntesis química , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Sistemas de Liberación de Medicamentos/instrumentación , Fumaratos/farmacocinética , Fumaratos/farmacología , Ensayo de Materiales , Microondas , Modelos Biológicos , Polímeros/síntesis química , Polímeros/química , Polímeros/farmacocinética , Polímeros/farmacología , Alcohol Polivinílico/química , Alcohol Polivinílico/farmacología , Solventes/farmacología , Resistencia a la Tracción , Agua/metabolismo
2.
Cardiol Clin ; 26(4): 527-35, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18929229

RESUMEN

Aliskiren, the first in a new class of orally effective direct renin inhibitors (DRIs) was recently approved for the treatment of hypertension. In this review, we discuss the history of the development of DRIs and available data regarding the effects of DRIs in the treatment of hypertension and related target organ damage.


Asunto(s)
Amidas/uso terapéutico , Antihipertensivos/uso terapéutico , Fumaratos/uso terapéutico , Hipertensión/tratamiento farmacológico , Renina/antagonistas & inhibidores , Amidas/farmacocinética , Amidas/farmacología , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Antihipertensivos/farmacocinética , Antihipertensivos/farmacología , Fumaratos/farmacocinética , Fumaratos/farmacología , Humanos , Hipertensión/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA